{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:54:38Z","timestamp":1792760078244,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T00:00:00Z","timestamp":1559779200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu","doi-asserted-by":"publisher","award":["502-14-03306413-10156"],"award-info":[{"award-number":["502-14-03306413-10156"]}],"id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s00228-019-02701-5","type":"journal-article","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T10:02:54Z","timestamp":1559815374000},"page":"1249-1259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Limited sampling strategy to predict mycophenolic acid area under the curve in pediatric patients with nephrotic syndrome: a retrospective cohort study"],"prefix":"10.1007","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2764-1575","authenticated-orcid":false,"given":"Joanna","family":"Sobiak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matylda","family":"Resztak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Pawi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawe\u0142","family":"\u017bero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danuta","family":"Ostalska-Nowicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Zachwieja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chrzanowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,6]]},"reference":[{"key":"2701_CR1","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.5114\/aoms.2011.26618","volume":"7","author":"D Ostalska-Nowicka","year":"2011","unstructured":"Ostalska-Nowicka D, Malinska A, Silska M, Perek B, Zachwieja J, Nowicki M (2011) Mycophenolate mofetil (MMF) treatment efficacy in children with primary and secondary glomerulonephritis. Arch Med Sci AMS 7:1042\u20131048. \n                    https:\/\/doi.org\/10.5114\/aoms.2011.26618","journal-title":"Arch Med Sci AMS"},{"key":"2701_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.4103\/0019-5545.49452","volume":"51","author":"P Guha","year":"2009","unstructured":"Guha P, De A, Ghosal M (2009) Behavior profile of children with nephrotic syndrome. Indian J Psychiatry 51:122\u2013126. \n                    https:\/\/doi.org\/10.4103\/0019-5545.49452","journal-title":"Indian J Psychiatry"},{"key":"2701_CR3","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s00467-013-2567-8","volume":"29","author":"MA Cadnapaphornchai","year":"2014","unstructured":"Cadnapaphornchai MA, Tkachenko O, Shchekochikhin D, Schrier RW (2014) The nephrotic syndrome: pathogenesis and treatment of edema formation and secondary complications. Pediatr Nephrol 29:1159\u20131167. \n                    https:\/\/doi.org\/10.1007\/s00467-013-2567-8","journal-title":"Pediatr Nephrol"},{"key":"2701_CR4","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00467-012-2310-x","volume":"28","author":"RM Lombel","year":"2013","unstructured":"Lombel RM, Gipson DS, Hodson EM (2013) Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO. Pediatr Nephrol 28:415\u2013426. \n                    https:\/\/doi.org\/10.1007\/s00467-012-2310-x","journal-title":"Pediatr Nephrol"},{"key":"2701_CR5","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00467-004-1765-9","volume":"20","author":"B T\u00f6nshoff","year":"2005","unstructured":"T\u00f6nshoff B, H\u00f6cker B, Weber LT (2005) Steroid withdrawal in pediatric and adult renal transplant recipients. Pediatr Nephrol 20:409\u2013417. \n                    https:\/\/doi.org\/10.1007\/s00467-004-1765-9","journal-title":"Pediatr Nephrol"},{"key":"2701_CR6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0140-6736(18)30536-1","volume":"392","author":"DG Noone","year":"2018","unstructured":"Noone DG, Iijima K, Parekh R (2018) Idiopathic nephrotic syndrome in children. Lancet 392:61\u201374. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(18)30536-1","journal-title":"Lancet"},{"key":"2701_CR7","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/FTD.0000000000000258","volume":"38","author":"\u00c1 Hackl","year":"2016","unstructured":"Hackl \u00c1, Cseprek\u00e1l O, Gessner M, Liebau MC, Habbig S, Ehren R, M\u00fcller C, Taylan C, D\u00f6tsch J, Weber LT (2016) Mycophenolate mofetil therapy in children with idiopathic nephrotic syndrome: does therapeutic drug monitoring make a difference? Ther Drug Monit 38:274\u2013279. \n                    https:\/\/doi.org\/10.1097\/FTD.0000000000000258","journal-title":"Ther Drug Monit"},{"key":"2701_CR8","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2215\/CJN.00320116","volume":"11","author":"S Tellier","year":"2016","unstructured":"Tellier S, Dallocchio A, Guigonis V, Saint-Marcoux F, Llanas B, Ichay L, Bandin F, Godron A, Morin D, Brochard K, Gandia P, Bouchet S, Marquet P, Decramer S, Harambat J (2016) Mycophenolic acid pharmacokinetics and relapse in children with steroid\u2013dependent idiopathic nephrotic syndrome. Clin J Am Soc Nephrol 11:1777\u20131782. \n                    https:\/\/doi.org\/10.2215\/CJN.00320116","journal-title":"Clin J Am Soc Nephrol"},{"key":"2701_CR9","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1365-2710.2008.00973.x","volume":"34","author":"T Pawinski","year":"2009","unstructured":"Pawinski T, Kunicki PK, Sobieszczanska-Malek M, Gralak B, Szlaska I (2009) A limited sampling strategy for estimating mycophenolic acid area under the curve in adult heart transplant patients treated with concomitant cyclosporine. J Clin Pharm Ther 34:89\u2013101. \n                    https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00973.x","journal-title":"J Clin Pharm Ther"},{"key":"2701_CR10","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1097\/01.ftd.0000246766.12872.12","volume":"28","author":"LT Weber","year":"2006","unstructured":"Weber LT, Hoecker B, Armstrong VW, Oellerich M, T\u00f6nshoff B (2006) Validation of an abbreviated pharmacokinetic profile for the estimation of mycophenolic acid exposure in pediatric renal transplant recipients. Ther Drug Monit 28:623\u2013631. \n                    https:\/\/doi.org\/10.1097\/01.ftd.0000246766.12872.12","journal-title":"Ther Drug Monit"},{"key":"2701_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1007\/s00467-002-1057-1","volume":"18","author":"E David-Neto","year":"2003","unstructured":"David-Neto E, Araujo LMP, Sumita NM et al (2003) Mycophenolic acid pharmacokinetics in stable pediatric renal transplantation. Pediatr Nephrol 18:266\u2013272. \n                    https:\/\/doi.org\/10.1007\/s00467-002-1057-1","journal-title":"Pediatr Nephrol"},{"key":"2701_CR12","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1432-2277.2004.tb00415.x","volume":"17","author":"G Filler","year":"2004","unstructured":"Filler G (2004) Abbreviated mycophenolic acid AUC from CO, C1, C2, and C4 is preferable in children after renal transplantation on mycophenolate mofetil and tacrolimus therapy. Transpl Int 17:120\u2013125. \n                    https:\/\/doi.org\/10.1111\/j.1432-2277.2004.tb00415.x","journal-title":"Transpl Int"},{"key":"2701_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1365-2710.2008.00896.x","volume":"33","author":"D Teshima","year":"2008","unstructured":"Teshima D, Maiguma T, Kaji H, Otsubo K, Kitagawa N, Okabe Y, Sugitani A, Tanaka M, Oishi R (2008) Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy. J Clin Pharm Ther 33:159\u2013163. \n                    https:\/\/doi.org\/10.1111\/j.1365-2710.2008.00896.x","journal-title":"J Clin Pharm Ther"},{"key":"2701_CR14","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1097\/FTD.0000000000000165","volume":"37","author":"W Cai","year":"2015","unstructured":"Cai W, Ye C, Sun X, Qin K, Qin Y, Zhao D, Wu F, Hu Y, Li H, Tan L (2015) Limited sampling strategy for predicting area under the concentration\u2013time curve for mycophenolic acid in Chinese adults receiving mycophenolate mofetil and tacrolimus early after renal transplantation. Ther Drug Monit 37:304\u2013310. \n                    https:\/\/doi.org\/10.1097\/FTD.0000000000000165","journal-title":"Ther Drug Monit"},{"key":"2701_CR15","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/FTD.0b013e318040ce0b","volume":"29","author":"Y Zicheng","year":"2007","unstructured":"Zicheng Y, Weixia Z, Hao C, Hongzhuan C (2007) Limited sampling strategy for the estimation of mycophenolic acid area under the plasma concentration-time curve in adult patients undergoing liver transplant. Ther Drug Monit 29:207\u2013214. \n                    https:\/\/doi.org\/10.1097\/FTD.0b013e318040ce0b","journal-title":"Ther Drug Monit"},{"key":"2701_CR16","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1016\/j.transproceed.2018.02.068","volume":"50","author":"W Cai","year":"2018","unstructured":"Cai W, Cai Q, Xiong N, Qin Y, Lai L, Sun X, Hu Y (2018) Limited sampling strategy for estimating mycophenolic acid exposure on day 7 post-transplant for two mycophenolate mofetil formulations derived from 20 Chinese renal transplant recipients. Transplant Proc 50:1298\u20131304. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2018.02.068","journal-title":"Transplant Proc"},{"key":"2701_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/FTD.0000000000000486","volume":"40","author":"EK Brooks","year":"2018","unstructured":"Brooks EK, Tett SE, Isbel NM, McWhinney B, Staatz CE (2018) Evaluation of multiple linear regression\u2013based limited sampling strategies for enteric-coated mycophenolate sodium in adult kidney transplant recipients. Ther Drug Monit 40:195\u2013201. \n                    https:\/\/doi.org\/10.1097\/FTD.0000000000000486","journal-title":"Ther Drug Monit"},{"key":"2701_CR18","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.phrs.2011.01.009","volume":"63","author":"F Saint-Marcoux","year":"2011","unstructured":"Saint-Marcoux F, Guigonis V, Decramer S, Gandia P, Ranchin B, Parant F, Bessenay L, Libert F, Harambat J, Bouchet S, Broux F, Compagnon P, Marquet P (2011) Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome. Pharmacol Res 63:423\u2013431. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2011.01.009","journal-title":"Pharmacol Res"},{"key":"2701_CR19","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2125.2010.03615.x","volume":"69","author":"W Zhao","year":"2010","unstructured":"Zhao W, Elie V, Baudouin V, Bensman A, Andr\u00e9 JL, Brochard K, Broux F, Cailliez M, Loirat C, Jacqz-Aigrain E (2010) Population pharmacokinetics and Bayesian estimator of mycophenolic acid in children with idiopathic nephrotic syndrome. Br J Clin Pharmacol 69:358\u2013366. \n                    https:\/\/doi.org\/10.1111\/j.1365-2125.2010.03615.x","journal-title":"Br J Clin Pharmacol"},{"key":"2701_CR20","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1007\/s13318-016-0358-x","volume":"42","author":"J Li","year":"2017","unstructured":"Li J, Yan K, Hou L, du X, Zhu P, Zheng L, Zhu C (2017) An algorithm and R program for fitting and simulation of pharmacokinetic and pharmacodynamic data. Eur J Drug Metab Pharmacokinet 42:499\u2013518. \n                    https:\/\/doi.org\/10.1007\/s13318-016-0358-x","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"2701_CR21","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1186\/s12874-017-0427-0","volume":"17","author":"S Pradhan","year":"2017","unstructured":"Pradhan S, Song B, Lee J, Chae JW, Kim KI, Back HM, Han N, Kwon KI, Yun HY (2017) Performance comparison of first-order conditional estimation with interaction and Bayesian estimation methods for estimating the population parameters and its distribution from data sets with a low number of subjects. BMC Med Res Methodol 17:154. \n                    https:\/\/doi.org\/10.1186\/s12874-017-0427-0","journal-title":"BMC Med Res Methodol"},{"key":"2701_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.ejps.2015.06.017","volume":"77","author":"J Sobiak","year":"2015","unstructured":"Sobiak J, Resztak M, Ostalska-Nowicka D, Zachwieja J, G\u0105siorowska K, Piechanowska W, Chrzanowska M (2015) Monitoring of mycophenolate mofetil metabolites in children with nephrotic syndrome and the proposed novel target values of pharmacokinetic parameters. Eur J Pharm Sci 77:189\u2013196. \n                    https:\/\/doi.org\/10.1016\/j.ejps.2015.06.017","journal-title":"Eur J Pharm Sci"},{"key":"2701_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jchromb.2007.09.036","volume":"859","author":"FA Elbarbry","year":"2007","unstructured":"Elbarbry FA, Shoker AS (2007) Liquid chromatographic determination of mycophenolic acid and its metabolites in human kidney transplant plasma: pharmacokinetic application. J Chromatogr B 859:276\u2013281. \n                    https:\/\/doi.org\/10.1016\/j.jchromb.2007.09.036","journal-title":"J Chromatogr B"},{"key":"2701_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1097\/FTD.0b013e31820f40f8","volume":"33","author":"MAF van der","year":"2011","unstructured":"van der MAF, Marcus MAE, Touw DJ et al (2011) Optimal sampling strategy development methodology using maximum a posteriori Bayesian estimation. Ther Drug Monit 33:133\u2013146. \n                    https:\/\/doi.org\/10.1097\/FTD.0b013e31820f40f8","journal-title":"Ther Drug Monit"},{"key":"2701_CR25","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/petr.12695","volume":"20","author":"LC Martial","year":"2016","unstructured":"Martial LC, Jacobs BAW, Cornelissen EAM, de Haan AFJ, Koch BCP, Burger DM, Aarnoutse RE, Schreuder MF, Br\u00fcggemann RJM (2016) Pharmacokinetics and target attainment of mycophenolate in pediatric renal transplant patients. Pediatr Transplant 20:492\u2013499. \n                    https:\/\/doi.org\/10.1111\/petr.12695","journal-title":"Pediatr Transplant"},{"key":"2701_CR26","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1159\/000445070","volume":"132","author":"K Tong","year":"2016","unstructured":"Tong K, Mao J, Fu H, Shen H, Liu A, Shu Q, du L (2016) The value of monitoring the serum concentration of mycophenolate mofetil in children with steroid-dependent\/frequent relapsing nephrotic syndrome. Nephron 132:327\u2013334. \n                    https:\/\/doi.org\/10.1159\/000445070","journal-title":"Nephron"},{"key":"2701_CR27","doi-asserted-by":"publisher","first-page":"162","DOI":"10.5414\/CN109583","volume":"91","author":"A Kirpalani","year":"2019","unstructured":"Kirpalani A, Rothfels L, Sharma AP, Cuellar CR, Filler G (2019) Nephrotic state substantially enhances apparent mycophenolic acid clearance. Clin Nephrol 91:162\u2013171. \n                    https:\/\/doi.org\/10.5414\/CN109583","journal-title":"Clin Nephrol"},{"key":"2701_CR28","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1034\/j.1399-3046.2002.02039.x","volume":"6","author":"G Filler","year":"2002","unstructured":"Filler G, Feber J, Lepage N, Weiler G, Mai I (2002) Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children. Pediatr Transplant 6:411\u2013418. \n                    https:\/\/doi.org\/10.1034\/j.1399-3046.2002.02039.x","journal-title":"Pediatr Transplant"},{"key":"2701_CR29","first-page":"135","volume":"8","author":"TM Attard","year":"2008","unstructured":"Attard TM, Dhawan A, Tredger JM et al (2008) Mycophenolic acid metabolite levels in pediatric liver transplantation: correlation with a limited sampling strategy. J Appl Res 8:135\u2013142","journal-title":"J Appl Res"},{"key":"2701_CR30","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1592\/phco.26.9.1232","volume":"26","author":"LSL Ting","year":"2006","unstructured":"Ting LSL, Partovi N, Levy RD, Riggs KW, Ensom MHH (2006) Limited sampling strategy for predicting area under the concentration-time curve of mycophenolic acid in adult lung transplant recipients. Pharmacother J Hum Pharmacol Drug Ther 26:1232\u20131240. \n                    https:\/\/doi.org\/10.1592\/phco.26.9.1232","journal-title":"Pharmacother J Hum Pharmacol Drug Ther"},{"key":"2701_CR31","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1016\/j.transproceed.2005.03.090","volume":"37","author":"M Baraldo","year":"2005","unstructured":"Baraldo M, Isola M, Feruglio MT, Francesconi A, Franceschi L, Tursi V, Livi U, Furlanut M (2005) Therapeutic mycophenolic acid monitoring by means of limited sampling strategy in orthotopic heart transplant patients. Transplant Proc 37:2240\u20132243. \n                    https:\/\/doi.org\/10.1016\/j.transproceed.2005.03.090","journal-title":"Transplant Proc"},{"key":"2701_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","volume":"46","author":"CE Staatz","year":"2007","unstructured":"Staatz CE, Tett SE (2007) Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet 46:13\u201358. \n                    https:\/\/doi.org\/10.2165\/00003088-200746010-00002","journal-title":"Clin Pharmacokinet"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02701-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02701-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02701-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,4]],"date-time":"2020-06-04T23:32:10Z","timestamp":1591313530000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02701-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,6]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["2701"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02701-5","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,6]]},"assertion":[{"value":"7 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Bioethical Committee at Poznan University of Medical Sciences.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent to participate was obtained from all parents or guardians of individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}